MULTIROS glatiramer acetate 20 mg/1mL solution for injection prefilled syringe

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

glatiramer acetate, Quantity: 20 mg/mL

Disponível em:

Juno Pharmaceuticals Pty Ltd

Forma farmacêutica:

Injection, solution

Composição:

Excipient Ingredients: mannitol; water for injections

Via de administração:

Subcutaneous

Unidades em pacote:

28

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Reduction of the frequency of relapses in patients with Relapsing Remitting Multiple Sclerosis.,Treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent MRI lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.

Resumo do produto:

Visual Identification: Clear solution in a clear, colourless glass syringe equipped with needle covered by a needle shield, stopper and piston rod.; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Registered

Data de autorização:

2020-11-12